Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Shenglu Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Natural Killer T-Cells, Liver Neoplasms, Bile Acids and Salts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Luzhou Administration of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim The impact of cholecystectomy, which blocks the cholecystohepatic shunt pathway (CHSP), on the prognosis of patients with hepatocellular carcinoma (HCC) is unclear. Hepatic secondary bile acids (BAs) inhibit natural killer T (NKT) cell‐mediated immunity against HCC, and the regulation of homeostasis of hepatic secondary BAs is controlled by the CHSP. However, the influence of CHSP on NKT cell‐mediated immunity against HCC remains unclear.
Methods
The clinical data of hospitalized patients undergoing HCC resection were collected. Meanwhile, an in situ HCC mouse model was established, and the CHSP was augmented using oleanolic acid (OA).
Results
After 1:1 propensity score matching, Cox regression analysis revealed that cholecystectomy was an independent risk factor for HCC recurrence after hepatectomy ( P = 0.027, hazard ratio: 1.599, 95% confidence interval: 1.055–2.422). Experimentally, when OA enhanced CHSP, a significant decrease was observed in the accumulation of secondary BAs in the livers of mice. Additionally, a significant increase was observed in the levels of C‐X‐C ligand 16 and interferon γ in the serum and tumor tissues. Further, the percentage of C‐X‐C receptor 6 (+) NKT cells in the tumor tissues increased significantly, and the growth of liver tumors was inhibited.
Conclusions
This clinical study revealed that cholecystectomy promoted the recurrence after radical hepatectomy in patients with HCC. Preserving the normal‐functioning gallbladder as much as possible during surgery may be beneficial to the patient's prognosis. Further investigation into the mechanism revealed that CHSP enhanced NKT cell‐mediated immunity against HCC by reducing the hepatic accumulation of secondary BAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Academician (Expert) Workstation of Sichuan Province, Metabolic Hepatobiliary and Pancreatic Diseases Key Laboratory of Luzhou City, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Hepatopancreatobiliary Surgery, Zizhong County People's Hospital, Neijiang, Sichuan, China.
ORCID-Profile: Shenglu Liu
Förderung
- Luzhou Administration of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Gou, H., Wei, H., Chen, S., Zhuo, S., Luo, M., Qin, S., Zhang, M., Chen, J., Huang, Z., Xia, X., Yang, X., & He, K. (2024). Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16548
Vancouver
Liu S, Gou H, Wei H, Chen S, Zhuo S, Luo M, et al. Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16548
BibTeX
@article{Liu2024,
author = {Liu, Shenglu and Gou, Haoxian and Wei, Hui and Chen, Shengdeng and Zhuo, Shijie and Luo, Ming and Qin, Shu and Zhang, Mengyu and Chen, Jiatong and Huang, Zhiwei and Xia, Xianming and Yang, Xiaoli and He, Kai},
title = {Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16548}
}
EUVIMED